These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22289918)

  • 1. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.
    Zucchetto A; Vaisitti T; Benedetti D; Tissino E; Bertagnolo V; Rossi D; Bomben R; Dal Bo M; Del Principe MI; Gorgone A; Pozzato G; Gaidano G; Del Poeta G; Malavasi F; Deaglio S; Gattei V
    Leukemia; 2012 Jun; 26(6):1301-12. PubMed ID: 22289918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
    Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
    Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.
    Dal Bo M; Tissino E; Benedetti D; Caldana C; Bomben R; Del Poeta G; Gaidano G; Rossi FM; Zucchetto A; Gattei V
    Semin Hematol; 2014 Jul; 51(3):168-76. PubMed ID: 25048781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
    Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
    Aydin S; Grabellus F; Eisele L; Möllmann M; Hanoun M; Ebeling P; Moritz T; Carpinteiro A; Nückel H; Sak A; Göthert JR; Dührsen U; Dürig J
    Eur J Haematol; 2011 Jul; 87(1):10-9. PubMed ID: 21692849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
    Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
    Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation.
    Pittner BT; Shanafelt TD; Kay NE; Jelinek DF
    Leukemia; 2005 Dec; 19(12):2264-72. PubMed ID: 16208411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.
    Ibrahem L; Elderiny WE; Elhelw L; Ismail M
    Blood Cells Mol Dis; 2015 Aug; 55(2):154-60. PubMed ID: 26142332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9.
    Buggins AG; Levi A; Gohil S; Fishlock K; Patten PE; Calle Y; Yallop D; Devereux S
    Br J Haematol; 2011 Jul; 154(2):216-22. PubMed ID: 21569005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells.
    Deaglio S; Vaisitti T; Zucchetto A; Gattei V; Malavasi F
    Semin Cancer Biol; 2010 Dec; 20(6):416-23. PubMed ID: 20817095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.
    Nückel H; Switala M; Collins CH; Sellmann L; Grosse-Wilde H; Dührsen U; Rebmann V
    Clin Immunol; 2009 Jun; 131(3):472-80. PubMed ID: 19318232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
    Poggi A; Prevosto C; Catellani S; Rocco I; Garuti A; Zocchi MR
    Br J Haematol; 2010 Nov; 151(3):252-64. PubMed ID: 20813004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
    Zucchetto A; Bomben R; Dal Bo M; Sonego P; Nanni P; Rupolo M; Bulian P; Dal Maso L; Del Poeta G; Del Principe MI; Degan M; Gattei V
    J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for Investigating VLA-4 (CD49d/CD29) Expression and Activation in Chronic Lymphocytic Leukemia and Its Clinical Applications.
    Zucchetto A; Tissino E; Chigaev A; Hartmann TN; Gattei V
    Methods Mol Biol; 2019; 1881():101-112. PubMed ID: 30350200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia.
    Finn WG; Singleton TP; Schnitzer B; Ross CW; Stoolman LM
    Hum Pathol; 2001 Jan; 32(1):66-73. PubMed ID: 11172297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
    Brachtl G; Piñón Hofbauer J; Greil R; Hartmann TN
    Ann Hematol; 2014 Mar; 93(3):361-74. PubMed ID: 24288111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma.
    Plander M; Ugocsai P; Seegers S; Orsó E; Reichle A; Schmitz G; Hofstädter F; Brockhoff G
    Ann Hematol; 2011 Dec; 90(12):1381-90. PubMed ID: 21465189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
    de la Fuente MT; Casanova B; Moyano JV; Garcia-Gila M; Sanz L; Garcia-Marco J; Silva A; Garcia-Pardo A
    J Leukoc Biol; 2002 Mar; 71(3):495-502. PubMed ID: 11867687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.
    Vaisitti T; Aydin S; Rossi D; Cottino F; Bergui L; D'Arena G; Bonello L; Horenstein AL; Brennan P; Pepper C; Gaidano G; Malavasi F; Deaglio S
    Leukemia; 2010 May; 24(5):958-69. PubMed ID: 20220774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.